Kohn, C. G., Lyman, G. H., Beyer-Westendorf, J., Spyropoulos, A. C., Bunz, T. J., Baker, W. L., … Coleman, C. I. (2018). Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 16(5), 491–497. https://doi.org/10.6004/jnccn.2018.7008

Kohn, Christine G., Gary H. Lyman, Jan Beyer-Westendorf, Alex C. Spyropoulos, Thomas J. Bunz, William L. Baker, Daniel Eriksson, Anna-Katharina Meinecke, and Craig I. Coleman. “Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis.” JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK 16, no. 5 (2018): 491–97. https://doi.org/10.6004/jnccn.2018.7008.

Kohn CG, Lyman GH, Beyer-Westendorf J, Spyropoulos AC, Bunz TJ, Baker WL, et al. Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. 2018;16(5):491–7.

Kohn, Christine G., et al. “Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis.” JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, vol. 16, no. 5, 2018, pp. 491–97. Wos-lite, doi:10.6004/jnccn.2018.7008.

Kohn CG, Lyman GH, Beyer-Westendorf J, Spyropoulos AC, Bunz TJ, Baker WL, Eriksson D, Meinecke A-K, Coleman CI. Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. 2018;16(5):491–497.